Key Developments: Smith & Nephew PLC (SNN.N)
22 May 2015
Latest Key Developments (Source: Significant Developments)
Smith & Nephew acquires interactive software technology to drive supply chain optimisation and improve savings for Syncera(tm) customers
Smith & Nephew PLC:Says the acquisition of two software assets from S2 Interactive, a surgical software development company.Software applications acquired by Smith & Nephew are Virtual Backtable (VBT) and TrayTouch.Terms of the transaction were not disclosed. Full Article
Smith & Nephew plc:Says that outlook for FY 2015 remains unchanged.Says that it continue to expect to deliver higher underlying revenue growth in FY 2015 than in FY 2014. Full Article
Smith & Nephew plc:Announces the acquisition of EuroCiencia Colombia (ECC).ECC has been Smith & Nephew's sole distributor for orthopaedic reconstruction, trauma and sports medicine products in Colombia since 2006.The terms of the transaction have not been disclosed. Full Article
Smith & Nephew plc:Acquires EuroCiencia Colombia.Says EuroCiencia Colombia has been Smith & Nephew's sole distributor for orthopaedic reconstruction, trauma and sports medicine products in Colombia since 2006.Terms of transaction have not been disclosed. Full Article
Smith & Nephew plc:expects the Group to deliver higher underlying revenue growth in FY 2015 than in FY 2014. Full Article
Smith & Nephew Plc:Says that a final dividend for 2014 of 18.6 US cents per ordinary share has been proposed.Says it will be payable, on May 6 to shareholders whose names appear on the register at the close of business on April 17.Says the ex-dividend date is April 16 and the final day for currency and dividend reinvestment plan elections is April 17. Full Article
Schweitzer-Mauduit International Inc:Signs a definitive agreement to acquire certain assets from Smith & Nephew's Advanced Wound Management division.As part of the transaction, SWM will acquire SNN's Gilberdyke, UK facility, which will become part of DelStar's operations.Site produces films, nets and foams, which are sold as components for first-aid and wound dressings, and have a variety of other medical applications.Transaction is expected to close once customary closing conditions are met, which is anticipated in advance of year-end; terms of the transaction were not disclosed.Smith & Nephew is headquartered in London, UK.Transaction is expected to be accretive beginning in 2015. Full Article
Smith & Nephew plc:Announces top line results from a Phase 3 study of HP802-247, a living cell spray-on therapy designed to work with the body's own cells to stimulate healing of venous leg ulcers.HP802-247 did not meet t he primary endpoint, namely a statistically improvement in healing over placebo, in a randomized, double-blind, vehicle-controlled study in North America.The result reported today announces full analysis of the efficacy data and study methodology is underway and will be completed in the coming months.A second Phase 3 study in the European Union, which is expected to report in 2016, will continue while the programme analysis is completed. Full Article
SENTENCE REMOVED - "Says that for FY 2014 it remains on track to meet guidance of mid teens revenue growth"....IN THE BODY (SEGMENTAL OUTLOOK).Smith & Nephew Plc:Says that for FY 2014 it remain confident in overall Group outlook. Full Article
- Beat A Volatile FTSE 100 With GlaxoSmithKline plc, Smith & Nephew plc, WPP PLC And Glencore PLC
- 3 FTSE 100 Stocks Set To Soar: SSE PLC, Smith & Nephew plc And Burberry Group plc
- AstraZeneca plc vs Smith & Nephew plc vs Indivior PLC: Which Healthcare Stock Should You Buy?
- Is The Reward Worth The Risk With BT Group plc, Admiral Group PLC, Smith & Nephew plc And Associated British Foods plc?
- Why Neil Woodford Has Sold Smith & Nephew Plc But Bought More Centrica Plc And SSE Plc
- Keep An Eye On Smith & Nephew plc & Shire plc Now!